Premium
Modulation of the ubiquitin‐proteasome proteolytic pathway by eicosapentaenoic acid supplementation in a model of progressive malignancy
Author(s) -
Mikhail AT,
Babcock TA,
Jho DH,
Helton WS,
Brodsky IG,
Espat NJ
Publication year - 2003
Publication title -
journal of parenteral and enteral nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.935
H-Index - 98
eISSN - 1941-2444
pISSN - 0148-6071
DOI - 10.1177/0148607103027002105
Subject(s) - eicosapentaenoic acid , corn oil , saline , endocrinology , medicine , vitamin e , skeletal muscle , chemistry , biology , fatty acid , biochemistry , polyunsaturated fatty acid , antioxidant
BACKGROUND: A benefit for eicosapentaenoic acid (EPA) supplementation for protein maintenance in cancer patients exists, although specific mechanisms are unknown. As the ubiquitin‐proteasome proteolytic (UPP) pathway has been implicated in protein use in malignancy, we determined mRNA levels for UPP components in the liver and muscles from EPA‐treated rats bearing the methylcholanthrene (MCA) fibrosarcoma. METHODS: Rats implanted with MCA tumor were divided into 3 groups on day 13: EPA (5 g/kg per day plus 10 IU vitamin E/g fat), corn oil (5 g/kg per day plus 10 IU vitamin E/g fat), and saline (5 g/kg per day plus 10 IU E/g saline). On day 29, tumor volume (TV) was determined; liver and quadriceps muscles were also excised to determine gene expression of C2, C3, E2(14k), and E3alpha by reverse transcription‐polymerase chain reaction (RT‐PCR). RESULTS: EPA‐treated rats demonstrated a reduced TV of 21% compared with the 28% and 30% TV of corn oil‐ and saline‐treated rats, respectively. Muscle mRNA levels of E2(14k) and E3alpha in EPA‐treated animals were decreased compared with corn oil‐ and saline‐treated animals. EPA treatment also decreased hepatic C2, C3, and E2(14k) mRNA levels compared with saline treatment. CONCLUSION: EPA supplement decreased skeletal muscle E2(14k), E3alpha, and hepatic C2 mRNA levels compared with the isocaloric, isonitrogenous corn oil supplement, supporting a treatment‐specific effect. The decrease in hepatic C3 and E2(14k) mRNA levels induced by EPA were partly because of caloric benefit and partly attributable to a treatment‐specific effect. Additionally, differences in the hepatic and muscle gene expressions of UPP components suggested an organ‐specific effect for omega‐3 fatty acid activity.